Gene-gene interactions lead to higher risk for development of type 2 diabetes in an Ashkenazi Jewish population

PLoS ONE

Volumn 5, Issue 3, 2013, Pages

  Neuman, Rosalind J ^a   Wasson, Jon ^a   Atzmon, Gil ^b   Wainstein, Julio ^d   Yerushalmi, Yair ^e   Cohen, Joseph ^f   Barzilai, Nir ^b   Blech, Ilana ^c   Glaser, Benjamin ^c   Permutt, M Alan ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d WOLFSON MEDICAL CENTER   (Israel)

^e CLALIT HEALTH SERVICES   (Israel)

^f Macabbi Health Service   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HNF1A PROTEIN, HUMAN; MEMBRANE PROTEIN; WOLFRAMIN PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; HUMAN; JEW; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; JEWS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 79952022272     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009903     Document Type: Article

References (46)

1. Mensink M (2005) Lifestyle intervention, glucose tolerance, and risk of developing type 2 diabetes mellitus. Metab Syndr Relat Disord 3: 26-34.
2. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362-9367.
3. Doria A, Patti ME, Kahn CR (2008) The emerging genetic architecture of type 2 diabetes. Cell Metab 8: 186-200.
4. Grant RW, Moore AF, Florez JC (2009) Genetic architecture of type 2 diabetes: recent progress and clinical implications. Diabetes Care 32: 1107-1114.
5. Black MH, Fingerlin TE, Allayee H, Zhang W, Xiang AH, et al. (2008) Evidence of interaction between PPARG2 and HNF4A contributing to variation in insulin sensitivity in Mexican Americans. Diabetes 57: 1048-1056.
6. Cauchi S, Meyre D, Durand E, Proenca C, Marre M, et al. (2008) Post genomewide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS One 3: e2031.
7. Hansen SK, Nielsen EM, Ek J, Andersen G, Glumer C, et al. (2005) Analysis of separate and combined effects of common variation in KCNJ11 and PPARG on risk of type 2 diabetes. J Clin Endocrinol Metab 90: 3629-3637.
8. Miyake K, Yang W, Hara K, Yasuda K, Horikawa Y, et al. (2009) Construction of a prediction model for type 2 diabetes mellitus in the Japanese population based on 11 genes with strong evidence of the association. J Hum Genet 54: 236-241.
9. Qi L, van Dam RM, Asselbergs FW, Hu FB (2007) Gene-gene interactions between HNF4A and KCNJ11 in predicting Type 2 diabetes in women. Diabet Med 24: 1187-1191.
10. Sparso T, Grarup N, Andreasen C, Albrechtsen A, Holmkvist J, et al. (2009) Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene-gene interaction. Diabetologia 52: 1308-1314.
11. Winckler W, Weedon MN, Graham RR, McCarroll SA, Purcell S, et al. (2007) Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes. Diabetes 56: 685-693.
12. Cho YM, Ritchie MD, Moore JH, Park JY, Lee KU, et al. (2004) Multifactordimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus. Diabetologia 47: 549-554.
13. Weedon MN, McCarthy MI, Hitman G, Walker M, Groves CJ, et al. (2006) Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med 3: e374.
14. Culverhouse R, Suarez BK, Lin J, Reich T (2002) A perspective on epistasis: limits of models displaying no main effect. Am J Hum Genet 70: 461-471.
15. Hanlon P, Lorenz WA, Shao Z, Harper JM, Galecki AT, et al. (2006) Threelocus and four-locus QTL interactions influence mouse insulin-like growth factor-I. Physiol Genomics 26: 46-54.
16. Jarvis JP, Cheverud JM (2009) Epistasis and the evolutionary dynamics of measured genotypic values during simulated serial bottlenecks. J Evol Biol 22: 1658-1668.
17. Barroso I, Luan J, Wheeler E, Whittaker P, Wasson J, et al. (2008) Populationspecific risk of type 2 diabetes conferred by HNF4A P2 promoter variants: a lesson for replication studies. Diabetes 57: 3161-3165.
18. Alsmadi O, Al-Rubeaan K, Wakil SM, Imtiaz F, Mohamed G, et al. (2008) Genetic study of Saudi diabetes (GSSD): significant association of the KCNJ11 E23K polymorphism with type 2 diabetes. Diabetes Metab Res Rev 24: 137-140.
19. Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, et al. (2003) Largescale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52: 568-572.
20. Love-Gregory L, Wasson J, Lin J, Skolnick G, Suarez B, et al. (2003) E23K single nucleotide polymorphism in the islet ATP-sensitive potassium channel gene (Kir6.2) contributes as much to the risk of Type II diabetes in Caucasians as the PPARgamma Pro12Ala variant. Diabetologia 46: 136-137.
21. Schwanstecher C, Meyer U, Schwanstecher M (2002) K(IR)6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP-sensitive K(+) channels. Diabetes 51: 875-879.
22. Florez JC, Jablonski KA, McAteer J, Sandhu MS, Wareham NJ, et al. (2008) Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program. Diabetologia 51: 451-457.
23. Franks PW, Rolandsson O, Debenham SL, Fawcett KA, Payne F, et al. (2008) Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations. Diabetologia 51: 458-463.
24. Minton JA, Hattersley AT, Owen K, McCarthy MI, Walker M, et al. (2002) Association studies of genetic variation in the WFS1 gene and type 2 diabetes in U.K. populations. Diabetes 51: 1287-1290.
25. Sandhu MS, Weedon MN, Fawcett KA, Wasson J, Debenham SL, et al. (2007) Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet 39: 951-953.
26. Wasson J, Permutt MA (2008) Candidate gene studies reveal that the WFS1 gene joins the expanding list of novel type 2 diabetes genes. Diabetologia 51: 391-393.
27. Moore JH, Gilbert JC, Tsai CT, Chiang FT, Holden T, et al. (2006) A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol 241: 252-261.
28. Permutt MA, Wasson JC, Suarez BK, Lin J, Thomas J, et al. (2001) A genome scan for type 2 diabetes susceptibility loci in a genetically isolated population. Diabetes 50: 681-685.
29. Jordes L (1992) Genetic Diseases in the Ashkenazi Population: Evolutionary Considerations. In: Bonné-Tamir B, Adam A, eds. Genetic Diversity Among Jews: Diseases and Markers at the DNA Level. New York: Oxford University Press. pp 305-318.
30. Atzmon G, Rincon M, Schechter CB, Shuldiner AR, Lipton RB, et al. (2006) Lipoprotein genotype and conserved pathway for exceptional longevity in humans. PLoS Biol 4: e113.
31. Barzilai N, Atzmon G, Schechter C, Schaefer EJ, Cupples AL, et al. (2003) Unique lipoprotein phenotype and genotype associated with exceptional longevity. Jama 290: 2030-2040.
32. Wasson J, Skolnick G, Love-Gregory L, Permutt MA (2002) Assessing allele frequencies of single nucleotide polymorphisms in DNA pools by pyrosequencing technology. Biotechniques 32: 1144-1146, 1148, 1150 passim.
33. Atzmon G, Pollin TI, Crandall J, Tanner K, Schechter CB, et al. (2008) Adiponectin levels and genotype: a potential regulator of life span in humans. J Gerontol A Biol Sci Med Sci 63: 447-453.
34. Botto LD, Khoury MJ (2001) Commentary: facing the challenge of geneenvironment interaction: the two-by-four table and beyond. Am J Epidemiol 153: 1016-1020.
35. Hunter DJ (2005) Gene-environment interactions in human diseases. Nat Rev Genet 6: 287-298.
36. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, et al. (2001) Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69: 138-147.
37. Hahn LW, Ritchie MD, Moore JH (2003) Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19: 376-382.
38. Velez DR, White BC, Motsinger AA, Bush WS, Ritchie MD, et al. (2007) A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction. Genet Epidemiol 31: 306-315.
39. Hastie T, Tibshiranai R, Friedman J (2001) The Elements of Statistical Learning:Data Mining, Inference, and Prediction. New York: Springer-Verlag.
40. Lou XY, Chen GB, Yan L, Ma JZ, Zhu J, et al. (2007) A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet 80: 1125-1137.
41. Weedon MN (2007) The importance of TCF7L2. Diabet Med 24: 1062-1066.
42. Hosmer DW, Lemeshow S (2000) Applied logistic regression New York: John Wiley & Sons Inc.
43. Frayling TM, Wiltshire S, Hitman GA, Walker M, Levy JC, et al. (2003) Youngonset type 2 diabetes families are the major contributors to genetic loci in the Diabetes UK Warren 2 genome scan and identify putative novel loci on chromosomes 8q21, 21q22, and 22q11. Diabetes 52: 1857-1863.
44. Franke L, van Bakel H, Fokkens L, de Jong ED, Egmont-Petersen M, et al. (2006) Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes. Am J Hum Genet 78: 1011-1025.
45. Riggs AC, Bernal-Mizrachi E, Ohsugi M, Wasson J, Fatrai S, et al. (2005) Mice conditionally lacking the Wolfram gene in pancreatic islet beta cells exhibit diabetes as a result of enhanced endoplasmic reticulum stress and apoptosis. Diabetologia 48: 2313-2321.
46. Pearson ER, Boj SF, Steele AM, Barrett T, Stals K, et al. (2007) Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med 4: e118.